Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy

References

• Agostini H T, Ryschkewitsch C F, Mory R, Singer E J, Stoner G L. JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PML. J. Infect Dis 1997; 176: 1–8
   Google Scholar
• Agostini H T, Ryschkewitsch C F, Singer E J, Stoner G L. Co‐infection with two JC virus genotypes in brain, cerebrospinal fluid or urinary tract detected by direct cycle sequencing of PCR products. J. Neurovirol 1996a; 2: 259–267
   Web of Science ®Google Scholar
• Agostini H T, Ryschkewitsch C F, Stoner G L. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J. Clin Microbiol 1996b; 34: 159–164
   PubMed Web of Science ®Google Scholar
• Ahmed S, Chowdhury M, Khalili K. Regulation of a human neurotropic virus promoter, JCVE: identification of a novel activator domain located upstream from the 98 bp enhancer promoter region. Nucleic Acids Res 1990; 18: 7417–7423
   PubMedGoogle Scholar
• Amemiya K, Traub R, Durham L, Major E O. Adjacent nuclear factor‐1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain‐specific genes. J Biol Chem 1992; 267: 14204–14211
   PubMedGoogle Scholar
• Arnheim N, Erlich H. Polymerase chain reaction strategy. Annu Rev Biochem 1992; 61: 131–156
   PubMed Web of Science ®Google Scholar
• Atwood W J, Wang L, Durham L C, Amemiya K, Traub R G, Major E O. Evaluation of “the role of cytokine activation in the multiplication of JC virus (JCV) in human fetal glial cells. J. Neurovirol 1995; 1: 40–49
   Web of Science ®Google Scholar
• Ault G S, Ryschkewitsch C F, Stoner G L. Type‐specific amplification of viral DNA using touchdown and hot start PCR. J. Virol Methods 1994; 46: 145–156
   PubMedGoogle Scholar
• Ault G S, Stoner G L. Two major types of JC virus denned in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J. Gen Virol 1992; 73: 2669–2678
   Google Scholar
• Ault G S, Stoner G L. Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure. J. Gen Virol 1993; 74: 1499–1507
   PubMed Web of Science ®Google Scholar
• Berger J R, Major E O. Progressive multifocal leukoencephalopathy ‘In Process Citation’. Semin Neurol 1999; 19: 193–200
   PubMed Web of Science ®Google Scholar
• Caldarelli‐Stefano R, Vago L, Omodeo‐Zorini E, Mediati M, Losciale L, Nebuloni M, Costanzi G, Ferrante P. Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non‐immunocompromised individuals ‘In Process Citation’. J. Neurovirol 1999; 5: 125–133
   PubMed Web of Science ®Google Scholar
• Chang C F, Otte J, Kerr D A, Valkkila M, Calkins C E, Khalili K. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells. Virology 1996; 221: 226–231
   Google Scholar
• Chang C F, Tada H, Khalili K. The role of a pentanucleotide repeat sequence, AGGGAAGGGA, in the regulation of JC virus DNA replication. Gene 1994; 148: 309–314
   PubMedGoogle Scholar
• Chowdhury M, Kundu M, Khalili K. GA/GC‐rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous svstem. Oncogene 1993; 8: 887–892
   PubMed Web of Science ®Google Scholar
• Ciappi S, Azzi A, De Santis R, Leoncini F, Sterrantino G, Mazzotta F, Mecocci L. Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. J. Gen Virol 1999; 80: 1017–1023
   PubMed Web of Science ®Google Scholar
• de Vries E, van Driel W, Tromp M, van Boom J, van der Vliet P C. Adenovirus DNA replication in vitro: site‐directed mutagenesis of the nuclear factor I binding site of the Ad2 origin. Nucleic Acids Res 1985; 13: 4935–4952
   PubMedGoogle Scholar
• Deyerle K L, Subramani S. Linker scan analysis of the early regulatory region of human papovavirus BK. J. Virol 1988; 62: 3378–3387
   PubMedGoogle Scholar
• Dörries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand 1998; 94: 71–79
   PubMedGoogle Scholar
• Eisner C, Dorries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992; 191: 72–80
   Google Scholar
• Eisner C, Dorries K. Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue. J. Gen Virol 1998; 79: 789–799
   Google Scholar
• Ferrante P, Omodeo‐Zorini E, Caldarelli‐Stefano R, Mediati M, Fainardi E, Granieri E, Caputo D. Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler 1998; 4: 49–54
   PubMed Web of Science ®Google Scholar
• Flaegstad T, Sundsfjord A, Arthur R R, Pedersen M, Traavik T, Subramani S. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction. Virology 1991; 180: 553–560
   PubMedGoogle Scholar
• Frisque R J, Bream G L, Cannella M T. Human polyomavirus JC virus genome. J. Virol 1984; 51: 458–469
   PubMed Web of Science ®Google Scholar
• Frisque R J, White F A. The molecular biology of JC virus, causative agent of progressive multifocal leukoencephalopathy. Molecular Neurovirology ‐Pathogenesis of viral CNS infections1st edn, R P Roos. Humana Press, Totowa 1992; Vol 1: 25–158
   Google Scholar
• Garcia de Viedma D, Alonso R, Miralles P, Berenguer J, Rodriguez‐Creixems M, Bouza E. Dual qualitative‐quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy ‘In Process Citation’. J. Clin Microbiol 1999; 37: 724–728
   Google Scholar
• Henson J, Saffer J, Furneaux H. The transcription factor Spl binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann Neurol 1992; 32: 72–77
   PubMedGoogle Scholar
• Henson J W. Regulation of the glial‐specific JC virus early promoter by the transcription factor Spl. J. Biol Chem 1994; 269: 1046–1050
   Google Scholar
• Houff S A, Major E O, Katz D A, Kufta C V, Sever J L, Pittaluga S, Roberts J R, Gitt J, Saini N, Lux W. Involvement of JC virus‐infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1988; 318: 301–305
   PubMed Web of Science ®Google Scholar
• Iida T, Kitamura T, Guo J, Taguchi F, Aso Y, Nagashima K, Yogo Y. Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 1993; 90: 5062–5065
   PubMedGoogle Scholar
• Johnson R T. The possible viral etiology of multiple sclerosis. Adv Neurol 1975; 13: 1–46
   PubMedGoogle Scholar
• Kerr D, Khalili K. A recombinant cDNA derived from human brain encodes a DNA binding protein that stimulates transcription of the human neurotropic virus JCV. J Biol Chem 1991; 266: 15876–15881
   Google Scholar
• Kitamura T, Satoh K, Tominaga T, Taguchi F, Tajima A, Suzuki K, Aso Y, Yogo Y. Alteration in the JC polyomavirus genome is enhanced in immunosuppress‐ed renal transplant patients. Virology 1994; 198: 341–345
   Google Scholar
• Koralnik I J, Boden D, Mai V X, Lord C I, Letvin N L. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy ‘In Process Citation’. Neurology 1999a; 52: 253–260
   PubMed Web of Science ®Google Scholar
• Koralnik I J, Schmitz J E, Lifton M A, Forman M A, Letvin N L. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV‐1‐infected individuals ‘In Process Citation’. J. Neurovirol 1999b; 5: 430–435
   PubMed Web of Science ®Google Scholar
• Krebs C J, McAvoy M T, Kumar G. The JC virus minimal core promoter is glial cell specific in vivo. J. Virol 1995; 69: 2434–2442
   Google Scholar
• Kumar G, Srivastava D K, Tefera W. A 70‐ to 80‐kDa glial cell protein interacts with the AGGGAA. G. G.‐GA domain of the JC virus early promoter only in the presence of the neighboring cis DNA elements. Virology 1994; 203: 116–124
   Google Scholar
• Kumar K U, Devireddy L R, Tang S C, Pater A, Pater M M. Human JC virus nuclear factor 1 binding motifs and large tumor antigen region required for transactivation of late promoter. J. Neurochem 1996; 67: 473–481
   Google Scholar
• Kumar K U, Pater A, Pater M M. Human JC virus perfect palindromic nuclear factor 1‐binding sequences important for glial cell‐specific expression in differentiating embryonal carcinoma cells. J. Virol 1993; 67: 572–576
   Google Scholar
• Leegwater P A, van Driel W, van der Vliet P C. Recognition site of nuclear factor I, a sequence‐specific DNA‐binding protein from HeLa cells that stimulates adenovirus DNA replication. EMBO J 1985; 4: 1515–1521
   PubMedGoogle Scholar
• Lynch K J, Frisque R J. Identification of critical elements within the JC virus DNA replication origin. J. Virol 1990; 64: 5812–5822
   PubMedGoogle Scholar
• Major E O, Amemiya K, Tornatore C S, Houff S A, Berger J R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus‐induced demyelinating disease of the human brain. Clin Microbiol Bev 1992; 5: 49–73
   PubMed Web of Science ®Google Scholar
• Martin J D, King D M, Slauch J M, Frisque R J. Differences in regulatory sequences of naturally occurring JC virus variants. J. Virol 1985; 53: 306–311
   PubMed Web of Science ®Google Scholar
• Newman J T, Frisque R J. Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient. J. Med Virol 1997; 52: 243–252
   PubMedGoogle Scholar
• Newman J T, Frisque R J. Identification of JC virus variants in multiple tissues of pediatric and adult PML patients. J Med Virol 1999; 58: 79–86
   PubMed Web of Science ®Google Scholar
• Padgett B L, Walker D L, Zu Rhein G M, Eckroade R J, Dessel B H. Cultivation of papova‐like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; i: 1257–1260
   Google Scholar
• Raj G V, Cupp C, Khalili K, Kim S J, Amini S. Soluble factors secreted by activated T‐lymphocytes modulate the transcription of the immunosuppressive cytokine TGF‐beta 2 in glial cells. J. Cell Biochem 1996; 62: 342–355
   Google Scholar
• Raj G V, Khalili K. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 1995; 213: 283–291
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Trequattrini A, Usai F, Murasecco D, Gallai V. Role of viruses in the etiopathogenesis of multiple sclerosis. Acta Neurol Napoli 1983; 15: 363–381
   Google Scholar
• Shinohara T, Nagashima K, Major E O. Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology 1997; 228: 269–277
   Google Scholar
• Stoner G L. Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis. Brain Pathol 1993; 3: 213–227
   Google Scholar
• Sugimoto C, Ito D, Tanaka K, Matsuda H, Saito H, Sakai H, Fujihara K, Itoyama Y, Yamada T, Kira J, Matsumoto R, Mori M, Nagashima K, Yogo Y. Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: diagnostic value for progressive multifocal leukoencephalopathy. Arch Virol 1998; 143: 249–262
   Google Scholar
• Sumner C, Shinohara T, Durham L, Traub R, Major E O, Amemiya K. Expression of multiple classes of the Nuclear Factor‐1 family in the developing human brain: differential expression of two classes of NF‐1 genes. J. Neurovirol 1996; 2: 87–100
   PubMed Web of Science ®Google Scholar
• Tada H, Lashgari M, Rappaport J, Khalili K. Cell type‐specific expression of JC virus early promoter is determined by positive and negative regulation. J. Virol 1989; 63: 463–466
   PubMedGoogle Scholar
• Vago L, Cinque P, Sala E, Nebuloni M, Caldarelli R, Racca S, Ferrante P, Trabottoni G, Costanzi G. JCV‐DNA and BKV‐DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J. Acquir Immune Defic Syndr Hum Betrovirol 1996; 12: 139–146
   Google Scholar
• Weber T, Frye S, Bodemer M, Otto M, Luke W. Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 1996; 2: 175–190
   Web of Science ®Google Scholar
• Weber T, Major E O. Progressive multifocal leukoencephalopathy: molecular biology, pathogenesis and clinical impact. Intervirology 1997; 40: 98–111
   PubMed Web of Science ®Google Scholar
• Weber T, Trebst C, Frye S, Cinque P, Vago L, Sindic C J, Schulz Schaeffer W J, Kretzschmar H A, Enzensberger W, Hunsmann G, Luke W. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect Dis 1997; 176: 250–254
   PubMed Web of Science ®Google Scholar
• Weber T, Turner R W, Frye S, Luke W, Kretzschmar H A, Liier W, Hunsmann G. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC Virus‐specific DNA from Cerebrospinal fluid. AIDS 1994; 8: 49–57
   PubMed Web of Science ®Google Scholar
• Wegner M, Drolet D W, Rosenfeld M G. Regulation of JC virus by the POU‐domain transcription factor Tst‐1: implications for progressive multifocal leukoencephalopathy. Proc Natl Acad Sci USA 1993; 90: 4743–4747
   PubMedGoogle Scholar
• White F A, Ishaq M, Stoner G L, Frisque R J. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J. Virol 1992; 66: 5726–5734
   PubMed Web of Science ®Google Scholar
• Yogo Y, Guo J, Iida T, Satoh K, Taguchi F, Takahashi H, Hall W W, Nagashima K. Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes 1994; 8: 99–105
   PubMedGoogle Scholar
• Yogo Y, Kitamura T, Sugimoto C, Hara K, Iida T, Taguchi F, Tajima A, Kawabe K, Aso Y. Sequence rearrangement in JC virus DNAs molecu‐larly cloned from immunosuppressed renal transplant patients. J. Virol 1991; 65: 2422–2428
   Google Scholar
• Yogo Y, Kitamura T, Sugimogo C, Ueki T, Aso Y, Hara K, Taguchi F. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompro‐mised individuals. J. Virol 1990; 64: 3139–3143
   PubMed Web of Science ®Google Scholar
• Zoltick P W, Mayreddy R P, Chang C F, Northrup B, Khalili K, Schwartzman R J. Isolation and characterization of a type II JC virus from a brain biopsy of a patient with PML. J. Neurovirol 1995; 1: 307–315
   PubMed Web of Science ®Google Scholar
• Zu Rhein G M, Chou S M. Particles resembling papovavirions in human cerebral demyelinating disease. Science 1965; 148: 1477–1479
   PubMedGoogle Scholar